Neuropathology of variants of progressive supranuclear palsy

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Progressive Supranuclear Palsy

Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930

The `subcortical dementia' of progressive supranuclear palsy

Albert, M. L., Feldman, R. G., & Willis, A. L. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.2.121 · Cited by 871

Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

Hauw, J., Daniel, S. E., Dickson, D. W., Horoupian, D. S., Jellinger, K. A., Lantos, P. L., McKee, A. C., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 854

Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A. M., Watt, H., Kilford, L., Holton, J. L., Révész, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 747

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 698

Pyramidal system involvement in progressive supranuclear palsy – a clinicopathological correlation

Stejskalova, Z., Rohan, Z., Rusina, R., Tesař, A., Kukal, J., Kovács, G. G., Bartoš, A., & Matěj, R. (2019) · BMC Neurology · doi:10.1186/s12883-019-1270-1 · Cited by 14

Neuropathology of Parkinson's Disease and ParkinsonismPreprint

Dickson, D. W. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041610 · Cited by 16

Cerebral white matter tau-positive granular glial pathology as a characteristic pathological feature in long survivors of multiple system atrophy

Homma, T., Mochizuki, Y., Tobisawa, S., Komori, T., & Isozaki, E. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117010 · Cited by 13

Human Wildtype Tau Expression in Cholinergic Pedunculopontine Tegmental Neurons is Sufficient to Produce PSP-like Behavioral Deficits and Neuropathology

King, G., Veros, K. M., MacLaren, D. A. A., Leigh, M. P. K., Spernyak, J. A., & Clark, S. D. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15496 · Cited by 12

Immunotherapy in progressive supranuclear palsy

Vaswani, P. A., & Olsen, A. L. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000836 · Cited by 13

Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy

Clark, H. M., Tosakulwong, N., Weigand, S. D., Ali, F., Botha, H., Pham, N. T. T., Schwarz, C. G., Reid, R. I., Senjem, M. L., Jack, C. R., et al. (2021) · Movement Disorders · doi:10.1002/mds.28731 · Cited by 13

Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect

Nasri, A., Sghaier, I., Neji, A., Gharbi, A., Abida, Y., Mrabet, S., Gargouri, A., Djebara, M. B., Kacem, I., & Gouider, R. (2024) · Journal of Movement Disorders · doi:10.14802/jmd.23178 · Cited by 14

Structural correlates of survival in progressive supranuclear palsy

Street, D., Bevan-Jones, W. R., Malpetti, M., Jones, P. S., Passamonti, L., Ghosh, B. C. P., Rittman, T., Coyle-Gilchrist, I. T. S., Allinson, K. S. J., Dawson, C. E., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105866 · Cited by 11

Cognitive impairment in Parkinson’s disease and other parkinsonian syndromes

Giannakis, A., Sioka, C., Kloufetou, E., & Konitsiotis, S. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02865-0 · Cited by 11

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Poloni, T. E., Medici, V., Carlos, A. F., Davin, A., Ceretti, A., Mangieri, M., Cassini, P., Vaccaro, R., Zaccaria, D., Abbondanza, S., et al. (2020) · Journal of Visualized Experiments · doi:10.3791/60296-v · Cited by 11

Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy

Badihian, N., Gatto, R. G., Satoh, R., Ali, F., Clark, H. M., Pham, N. T. T., Whitwell, J. L., & Josephs, K. A. (2024) · European Journal of Neurology · doi:10.1111/ene.16320 · Cited by 12

Track density imaging in progressive supranuclear palsy: A pilot study

Nigro, S. L., Bianco, M. G., Arabia, G., Morelli, M., Nisticò, R., Novellino, F., Salsone, M., Augimeri, A., & Quattrone, A. (2018) · Human Brain Mapping · doi:10.1002/hbm.24484 · Cited by 10

Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review

Bendstrup, N., Hejl, A., & Salvesen, L. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215616 · Cited by 11

Prospective Characterization of Cognitive Function in Typical and ‘Brainstem Predominant’Progressive Supranuclear Palsy Phenotypes

Lee, C., Williams, D. R., & Anderson, J. F. I. (2018) · Journal of Movement Disorders · doi:10.14802/jmd.17067 · Cited by 11

Atypical progressive supranuclear palsy presenting as primary lateral sclerosis

King, A., Curran, O. E., & Al‐Sarraj, S. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.015 · Cited by 11

Aetiology and pathophysiology of neurodegenerative disorders

Sahoo, R. K., Gupta, T., Smily, Kumar, V., Rani, S., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00006-x · Cited by 13

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer’s disease

Jaillard, A., Vanhoutte, M., Maureille, A., Schraen‐Maschke, S., Skrobala, E., Delbeuck, X., Rollin‐Sillaire, A., Pasquier, F., Bombois, S., & Semah, F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4113-1 · Cited by 12

Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy

Valentino, R. R., Koga, S., Heckman, M. G., Brushaber, D. E., Diehl, N. N., Walton, R. L., Dickson, D. W., & Ross, O. A. (2020) · Movement Disorders · doi:10.1002/mds.28010 · Cited by 10

18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty

Hsu, J., Chen, S.-H., Hsiao, I., Lu, C., Yen, T., Okamura, N., Lin, K., & Weng, Y.-H. (2020) · Scientific Reports · doi:10.1038/s41598-020-76339-0 · Cited by 12

Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component

Müller, U., Höglinger, G. U., & Dickson, D. W. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02898-z · Cited by 10

Neurodegenerative diseases

Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00012-2 · Cited by 10

Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions

Dale, M. L., Silva‐Batista, C., de Almeida, F. O., & Horak, F. B. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1212185 · Cited by 9

Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia

Ng, A. S. L., Tan, A. H., Tan, Y. J., Lim, J. L., Lian, M. M., Closas, A. M. F. D., Ahmad‐Annuar, A., Viswanathan, S., Chia, Y. K., Foo, J. N., et al. (2024) · Movement Disorders · doi:10.1002/mds.29932 · Cited by 10

123I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes

Hellwig, S., Kreft, A., Amtage, F., Tüscher, O., Winz, O., Hellwig, B., Weiller, C., Weber, W., Vach, W., & Meyer, P. T. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122010 · Cited by 9

Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra

You, Y., Botros, M. B., Enoo, A. A. V., Bockmiller, A., Herron, S., Delpech, J.-C., & Ikezu, T. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.001 · Cited by 9

Sex-Related Motor Deficits in the Tau-P301L Mouse Model

Camargo, L. C., Honold, D., Bauer, R., Shah, N. J., Langen, K., Willbold, D., Kutzsche, J., Willuweit, A., & Schemmert, S. (2021) · Biomedicines · doi:10.3390/biomedicines9091160 · Cited by 9

iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression

Strauß, T., Marvian, A. T., Sadikoglou, E., Dhingra, A., Wegner, F., Trümbach, D., Wurst, W., Heutink, P., Schwarz, S. C., & Höglinger, G. U. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.726866 · Cited by 13

Language capacities in dementia

(2013) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2013.00208 · Cited by 10

Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants

Orlandi, F., Carlos, A. F., Ali, F., Clark, H. M., Duffy, J. R., Utianski, R. L., Botha, H., Machulda, M. M., Stephens, Y. C., Schwarz, C. G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae113 · Cited by 8

Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy

Koizumi, R., Akagi, A., Riku, Y., Miyahara, H., Sone, J., Tanaka, F., Yoshida, M., & Iwasaki, Y. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106076 · Cited by 8

Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies

Frey, K. A. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.003 · Cited by 8

Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression

Zheng, M., Jiao, L., Tang, X., Xiang, X., Wan, X., Yan, Y., Li, X., Zhang, G., Li, Y., Jiang, B., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601303r · Cited by 8

Role of molecular polymorphism in defining tau filament structures in neurodegenerative diseasesPreprint

Xiang, X., Arakhamia, T., Carlomagno, Y., Dhingra, S., Thierry, M., Deture, M. A., Cook, C. N., Dickson, D. W., Petrucelli, L., & Fitzpatrick, A. W. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.24.445353 · Cited by 7

Patterns of Longitudinal Regional Brain Atrophy in Patients With Different Progressive Supranuclear Palsy Clinical Variants

Kumar, M., Tosakulwong, N., Weigand, S. D., Ali, F., Stephens, Y. C., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Jack, C. R., Josephs, K. A., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214434 · Cited by 7

Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations

Eusébio, A., Koric, L., Félician, O., Guedj, E., Ceccaldi, M. P., & Azulay, J. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.009 · Cited by 7

Neuropathological analysis of cognitive impairment in progressive supranuclear palsy

Sakuwa, M., Adachi, T., Suzuki, Y., Takigawa, H., & Hanajima, R. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120718 · Cited by 8

Differentiating neurodegenerative parkinsonian syndromes using vestibular evoked myogenic potentials and balance assessment

Klunk, D., Woost, T. B., Fricke, C., Claßen, J., & Weise, D. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.08.012 · Cited by 7

The tauopathies: Neuroimaging characteristics and emerging experimental therapies

Riley, K. J., Graner, B. D., & Veronesi, M. C. (2022) · Journal of Neuroimaging · doi:10.1111/jon.13001 · Cited by 8

Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6

Isella, V., Licciardo, D., Ferri, F., Crivellaro, C., Morzenti, S., Appollonio, I. M., & Ferrarese, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.969875 · Cited by 7

Slowing of Frontal β Oscillations in Atypical Parkinsonism

Krösche, M., Kannenberg, S., Butz, M., Hartmann, C. J., Florin, E., Schnitzler, A., & Hirschmann, J. V. (2023) · Movement Disorders · doi:10.1002/mds.29378 · Cited by 9

Phosphorylated a-Synuclein in Parkinson's Disease

Wang, Y., Shi, M. Y., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., Srulijes, K., Trojanowski, J. Q., Lee, Y.-K., Siderowf, A. D., et al. (2016) · Cited by 7

Pathological Study of a FMR1 Premutation Carrier With Progressive Supranuclear Palsy

Paucar, M., Nennesmo, I., & Svenningsson, P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00317 · Cited by 7

Single-cell atlas of progressive supranuclear palsy reveals a distinct hybrid glial cell populationPreprint

Sharma, A., Song, W.-M., Farrell, K., Whitney, K., Zhang, B., Crary, J., & Pereira, A. C. (2021) · bioRxiv · doi:10.1101/2021.04.11.439393 · Cited by 7

Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy

Ibrahim, V., Isroff, C. E., Stephen, C. D., Iyer, J. M., Dale, M. L., Gunzler, D. A., Bayram, E., Xie, T., Pantelyat, A. Y., Montaser‐Kouhsari, L., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1501206 · Cited by 6

Supranuclear Palsy as an Initial Presentation of the Adult-Onset Niemann-Pick Type C

Mohamed, A. A., Gan, W., Babici, D., Hagan, V., Wald, R., & Swerdloff, M. A. (2024) · Neurology International · doi:10.3390/neurolint16030042 · Cited by 6

High rates of diagnostic discordance and co‐pathology: Insights into PSP from the NACC dataset

Popli, T. A., Pal, S., Gregoire, A., Reader, J. M., Passamani, A., Bakulski, K. M., Bhaumik, A., Pinarbasi, E. S., Paulson, H. L., & Maher, A. C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70248 · Cited by 6

Sleep Architecture in Progressive Supranuclear Palsy

Boini, S. Y., Mahale, R. R., Donaparthi, S., Kamble, N. L., Holla, V. V., Pal, P. K., Kutty, B. M., & Yadav, R. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_1096_21 · Cited by 6

Visual Search in Progressive Supranuclear Palsy

Smith, D. T., & Archibald, N. K. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_72 · Cited by 6

Emerging drugs for progressive supranuclear palsy

Giagkou, N., & Stamelou, M. (2019) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2019.1609450 · Cited by 6

Parkinson’s Disease and Parkinsonism

Soyukibar, T. E., & Kaya, D. (2022) · The Journal of Turkish Family Physician · doi:10.15511/tjtfp.22.00482 · Cited by 6

Optogenetic investigation into the role of the subthalamic nucleus in motor controlPreprint

Guillaumin, A., Serra, G. P., Georges, F. E., & Wallén‐Mackenzie, Å. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.08.193359 · Cited by 6

Frontotemporal Dementia (FTD)

Bertoux, M., O’Callaghan, C., Flanagan, E. C., & Hornberger, M. (2016) · Springer eBooks · doi:10.1007/978-981-287-080-3_311-1 · Cited by 6

Brain Microstructure Interrogation by Diffusion Tensor and Kurtosis Imaging in Progressive Supranuclear Palsy Subtypes

Gatto, R. G., Youssef, H., Pham, N. T. T., Ali, F., Clark, H. M., Stierwalt, J. A. G., Stephens, Y. C., Machulda, M. M., Josephs, K. A., & Whitwell, J. L. (2025) · Journal of Neuroimaging · doi:10.1111/jon.70062 · Cited by 5

Progressive Supranuclear Palsy

Morris, H. R. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00021-0 · Cited by 5

Atypical association of semantic dementia, corticobasal syndrome, and 4R tauopathy

Clerc, M.-T., Deprez, M., Leuba, G., Lhermitte, B., Lopez, U., & von Gunten, A. (2013) · Neurocase · doi:10.1080/13554794.2013.841953 · Cited by 5

An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau

Beck, G., Yamashita, R., Kido, K., Ikenaka, K., Chiba, T., Yonenobu, Y., Saito, Y., Morii, E., Hasegawa, M., Murayama, S., et al. (2023) · Neuropathology · doi:10.1111/neup.12890 · Cited by 5

CLINICAL AND RADIOLOGIC APPROACH TO PROBABLE MIXED DEMENTIA (VASCULAR DEMENTIA AND PROGRESSIVE SUPRANUCLEAR PALSY)

Lastri, D. N., & Alwahdy, A. S. (2020) · MNJ (Malang Neurology Journal) · doi:10.21776/ub.mnj.2020.006.01.10 · Cited by 5

Targeting cellular batteries for the therapy of neurological diseases

Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Mathew, B., & BUNGAU, S. G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14665-0 · Cited by 5

Comorbidities

Alafuzoff, I. I., & Kovács, G. G. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00036-5 · Cited by 5

Multireceptor fingerprints in progressive supranuclear palsy

Chiu, W. Z., Kaat, L. D., Boon, A. J. W., Kamphorst, W., Schleicher, A., Zilles, K., Swieten, J. C. V., & Palomero‐Gallagher, N. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0259-5 · Cited by 5

Language in Dementia

Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921 · Cited by 4

Cell-specific mitochondrial response in progressive supranuclear palsy

Sackmann, V., Nassir, N., Tanikawa, S., Forrest, S. L., Chasiotis, H., Li, J., Hanif, S., Martínez-Valbuena, I., Tartaglia, M. C., Lang, A. E., et al. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102043 · Cited by 4

Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study

Ono, D., Sekiya, H., Ghayal, N. B., Maier, A. R., Roemer, S. F., Uitti, R. J., Litvan, I., Josephs, K. A., Wszołek, Z. K., & Dickson, D. W. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13459-5 · Cited by 4

Pathology and pathophysiology

Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4

Progressive Supranuclear Palsy

Agarwal, S., & Gilbert, R. (2019) · StatPearls · Cited by 4

Neuropathologie der Demenzen

Klotz, S., & Gelpí, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00848-4 · Cited by 4

Deafferentation of Olfactory Bulb in Subjects Dying with COVID-19Preprint

Tremblay, C., Beach, T. G., Intorcia, A. J., Walker, J. E., Arce, R. A., Sue, L. I., Nelson, C. M., Borja, C. I., Suszczewicz, K. E., Cline, M. P., et al. (2021) · medRxiv · doi:10.1101/2021.12.21.21268119 · Cited by 4

A 15-Item modification of the PSP rating scale to improve clinical meaningfulness and statistical performance

Dam, T., Yang, L., Gillis, C., Li, Y., O'Gorman, J. T., Kolb, B., Boxer, A. L., Golbe, L. I., Haeberlein, S. B., & On behalf of the AL-108-231, P. (2025) · Nature Communications · doi:10.1038/s41467-024-55442-0 · Cited by 3

Can Progressive Supranuclear Palsy Be Accurately Identified via MRI with the Use of Visual Rating Scales and Signs?

Anyfantakis, G., Manouvelou, S., Koutoulidis, V., Velonakis, G., Scarmeas, N., & Papageorgiou, S. G. (2025) · Biomedicines · doi:10.3390/biomedicines13051009 · Cited by 3

Beyond Parkinson's Disease: A Narrative Review of Neuromelanin MRI in Neurodegenerative Diseases

Burade, A., Lakhani, D. A., Dagher, R., Anosh, J., Sair, H. I., & Luna, L. (2025) · Journal of Neuroimaging · doi:10.1111/jon.70113 · Cited by 3

Targeting pyroptosis in tauopathies: A redox-driven axis of neuroinflammation and neurodegeneration

López, E. A., Silva-Llanes, I., Diez-Tejedor, E., & Lastres‐Becker, I. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.029 · Cited by 4

Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly

Fernández-Ferreira, R., García-Santos, R. A., Rodríguez‐Violante, M., López-Martínez, C., Becerra‐Laparra, I. K., & Torres-Pérez, M. E. (2019) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2019.04.002 · Cited by 3

Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies

Satoh, R., Sekiya, H., Ali, F., Clark, H. M., Utianski, R. L., Duffy, J. R., Machulda, M. M., Dickson, D. W., Josephs, K. A., & Whitwell, J. L. (2025) · Annals of Neurology · doi:10.1002/ana.27286 · Cited by 4

Globular glial tauopathy, a newly recognized white matter tauopathy, with depression/anxiety disorder: report and review of classification

Kurdi, M. E., Alghamdi, B. S. A., Parfitt, J. R., & Ang, L. C. (2021) · Folia Neuropathologica · doi:10.5114/fn.2021.104396 · Cited by 3

Alzheimer’s Dementia

Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.001 · Cited by 3

Primary Progressive Aphasia

Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.002 · Cited by 3

Rehabilitation Interventions Using Immersive Virtual Reality for People With Parkinson’s Disease: A Systematic Review and Meta-Analysis

Piette, P., Fraudet, B., Vinatier, C., Leblong, É., & Galien, P. (2022) · International Journal of Physiotherapy and Research · doi:10.16965/ijpr.2022.121 · Cited by 2

An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration

Kuru, S., Sakai, M., Moriyoshi, H., Miyahara, H., & Iwasaki, Y. (2024) · Neuropathology · doi:10.1111/neup.13001 · Cited by 3

Comorbid pathologies and their impact on progressive supranuclear palsy: current view

Jellinger, K. A. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03005-y · Cited by 3

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia

Menšíková, K., Tučková, L., Ehrmann, J., & Kaňovský, P. (2016) · Medicine · doi:10.1097/md.0000000000005237 · Cited by 3

Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies

Méduri, G., Guillemeau, K., Daguinot, C., Dounane, O., Genet, M., Ferrara, L., Chambraud, B., Baulieu, E. E., & Giustiniani, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230127 · Cited by 3

White Matter β-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19Preprint

Beach, T. G., Deture, M. A., Walker, J. E., Arce, R. A., Glass, M. J., Sue, L. I., Intorcia, A. J., Nelson, C. M., Suszczewicz, K. E., Borja, C. I., et al. (2021) · medRxiv · doi:10.1101/2021.12.16.21266656 · Cited by 3

Progressive Supranuclear Palsy and Corticobasal Syndrome

McFarland, N. R. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001607 · Cited by 2

Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis

Wang, B., Wang, H., Kang, Y., Wu, S., Jin, N., Wang, H., Cen, Z., Yang, D., Chen, X., Dou, X., et al. (2025) · Movement Disorders · doi:10.1002/mds.70099 · Cited by 2

Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy – Richardson syndrome

Homma, T., Mochizuki, Y., Hara, M., Kamei, S., Mizutani, T., Takubo, H., Isozaki, E., Takahashi, M., Komori, T., & Hao, H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.09.010 · Cited by 2

Visual fixation suppression of caloric nystagmus in progressive supranuclear palsy – A comparison with Parkinson’s disease

Naito, R., Watanabe, Y. S., Naito, A., Sugasawa, K., Nakata, Y., Kamiyama, T., Okiyama, R., Yokochi, F., Isozaki, E., Yamasoba, T., et al. (2023) · Journal of Vestibular Research · doi:10.3233/ves-210147 · Cited by 2

Detection and classification of progressive supranuclear palsy from MRI images using deep learning

Sait, N. A., & Kathirvelan, J. (2024) · Journal of Applied Research and Technology · doi:10.22201/icat.24486736e.2024.22.1.2228 · Cited by 2

Machine Learning Models of Voxel‐Level [18F] Fluorodeoxyglucose Positron Emission Tomography Data Excel at Predicting Progressive Supranuclear Palsy Pathology

Braun, A. S., Satoh, R., Pham, N. T. T., Singh, N. A., Ali, F., Dickson, D. W., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2025) · Annals of Neurology · doi:10.1002/ana.27265 · Cited by 2

Diffusion Tensor Imaging in Progressive Supranuclear Palsy Versus Other Neurodegenerative Diseases: A Review

Giannakis, A., Konitsiotis, S., & Xiromerisiou, G. (2025) · Journal of Neuroimaging · doi:10.1111/jon.70063 · Cited by 2

An Unusual Presentation of Progressive Supranuclear Palsy

Dec‐Ćwiek, M., Boczarska‐Jedynak, M., & Pera, J. (2021) · Neurology India · doi:10.4103/0028-3886.333499 · Cited by 2

Progressive Supranuclear Palsy and Related Parkinsonian Disorders

Brown, J. A., & Seeley, W. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00018-4 · Cited by 2

Transitory alternating saccade in a case with frontotemporal dementia caused by progressive supranuclear palsy

Yokota, J.-I., Motoi, Y., & Yamaguchi, Y. (2018) · Equilibrium Research · doi:10.3757/jser.77.77 · Cited by 2

Clinical heterogeneity of progressive supranuclear palsy

Tappakhov, A. A., Popova, T. E., Govorova, T. G., & Petrova, A. Y. (2018) · Annals of Clinical and Experimental Neurology · doi:10.17816/acen.2018.2.5 · Cited by 2

Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?

Savoie, F.-A., Arpin, D. J., & Vaillancourt, D. E. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230801140648 · Cited by 3

Progressive supranuclear palsy

Moore, C. L. H., & Singer, C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977749.003 · Cited by 2

Somatosensory area 3b is selectively unaffected in corticobasal syndrome: combining MRI and histology

Dinkelbach, L., Südmeyer, M., Hartmann, C. J., Roeber, S., Arzberger, T., Felsberg, J., Ferrea, S., Moldovan, A., Amunts, K., Schnitzler, A., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.05.009 · Cited by 2

Progressive supranuclear palsy presenting as primary lateral sclerosis

Nagao, S., Yokota, O., Ikeda, C., Terada, S., Ihara, Y., & Uchitomi, Y. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.016 · Cited by 2

Progressive Supranuclear Palsy (PSP)

Vaughan, C. L., & Goetz, C. G. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.00031-2 · Cited by 2

Progressive Supranuclear Palsy

Morris, H. R. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch8 · Cited by 2

Slowing of Frontocentral Beta Oscillations in Atypical ParkinsonismPreprint

Krösche, M., Kannenberg, S., Butz, M., Hartmann, C. J., Florin, E., Schnitzler, A., & Hirschmann, J. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.19.488835 · Cited by 3

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant

Ling, H., de Silva, R., Massey, L. A., Courtney, R. J., Hondhamuni, G., Bajaj, N. P. S., Lowe, J. S., Holton, J. L., Lees, A. J., & Révész, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12037 · Cited by 97

Progressive supranuclear palsy: what's new?

Lévy, R. (2011) · Gériatrie et Psychologie Neuropsychiatrie du Viellissement · doi:10.1684/pnv.2011.0271 · Cited by 2

202: Severity of tau deposition in progressive supranuclear palsy is associated with clinical phenotype

Williams, D. R., Holton, J. L., Strand, K. M., Pittman, A. M., de Silva, R., Lees, A. J., & Révész, T. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.07.006

Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants

Orlandi, F., Carlos, A. F., Ali, F., Clark, H. M., Duffy, J. R., Utianski, R. L., Botha, H., Machulda, M. M., Stephens, Y. C., Schwarz, C. G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae113 · Cited by 8

Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy

Koizumi, R., Akagi, A., Riku, Y., Miyahara, H., Sone, J., Tanaka, F., Yoshida, M., & Iwasaki, Y. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106076 · Cited by 8